MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1

Oncogene

Volumn 31, Issue 11, 2012, Pages 1398-1407

  Xu, Y ^a   Zhao, F ^a   Wang, Z ^a   Song, Y ^a   Luo, Y ^a   Zhang, X ^a   Jiang, L ^a   Sun, Z ^a   Miao, Z ^a   Xu, H ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; LUCIFERASE; MATRIGEL; MICRORNA; MICRORNA 335; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL W; PROTEIN KINASE B; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER STAGING; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH; STOMACH CANCER; WESTERN BLOTTING;

APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RNA INTERFERENCE; SP1 TRANSCRIPTION FACTOR; STOMACH NEOPLASMS;

EID: 84858336969     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.340     Document Type: Article

References (49)

1. Antonsson B. (2001). Bax and other pro-Apoptotic Bcl-2 family "killerproteins" and their victim the mitochondrion. Cell Tissue Res 306: 347-361.
2. Bae IH, Park MJ, Yoon SH, Kang SW, Lee SS, Choi KM et al. (2006). Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt, and Sp1. Cancer Res 66: 4991-4995.
3. Bae IH, Yoon SH, Lee SB, Park JK, Ho JN, Um HD. (2009). Signaling components involved in Bcl-w-induced migration of gastric cancer cells. Cancer Lett 277: 22-28.
4. Bartel DP. (2004). MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
5. Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E et al. (2009). Recent patterns in gastric cancer: A global overview. Int J Cancer 125: 666-673.
6. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE et al. (2007). p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 17: 1298-1307.
7. Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC et al. (2004). A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119: 591-602.
8. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. (2002). Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99: 15524-15529.
9. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S et al. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004.
10. Chen Y, Song Y, Wang Z, Yue Z, Xu H, Xing C et al. (2010). Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J Gastrointest Surg 14: 1170-1179.
11. Chiang Y, Song Y, Wang Z, Chen Y, Yue Z, Xu H et al. (2010). Aberrant expression of miR-203 and its clinical significance in gastric and colorectal cancers. J Gastrointest Surg 15: 63-70.
12. Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N et al. (2006). Pre-B cell proliferation and lymphoblastic leukemia/highgrade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci USA 103: 7024-7029.
13. Du Y, Xu Y, Ding L, Yao H, Yu H, Zhou T et al. (2009). Downregulation of miR-141 in gastric cancer and its involvement in cell growth. J Gastroenterol 44: 556-561.
14. Gironella M, Seux M, Xie MJ, Cano C, Tomasini R, Gommeaux J et al. (2007). Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci USA 104: 16170-16175.
15. Gross A, McDonnell JM, Korsmeyer SJ. (1999). BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899-1911.
16. Jiang CG, Wang ZN, Sun Z, Liu FN, Yu M, Xu HM. (2010). Clinicopathologic characteristics and prognosis of gastric cancer invading the subserosa. J Surg Oncol 102: 737-741.
17. Kanai M, Wei D, Li Q, Jia Z, Ajani J, Le X et al. (2006). Loss of Krüppel-like factor 4 expression contributes to Sp1 overexpression and human gastric cancer development and progression. Clin Cancer Res 12: 6395-6402.
18. Kim YK, Yu J, Han TS, Park SY, Namkoong B, Kim DH et al. (2009). Functional links between clustered microRNAs: Suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res 37: 1672-1681.
19. Kuo L, Chang HC, Leu TH, Maa MC, Hung WC. (2006). Src oncogene activates MMP-2 expression via the ERK/Sp1 pathway. J Cell Physiol 207: 729-734.
20. Lee HW, Lee SS, Lee SJ, Um HD. (2003). Bcl-w is expressed in a majority of infiltrative gastric adenocarcinomas and suppresses the cancer cell death by blocking stress-Activated protein kinase/c-Jun NH2-terminal kinase activation. Cancer Res 63: 1093-1100.
21. Liu T, Tang H, Lang Y, Liu M, Li X. (2008). MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett 273: 233-242.
22. Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
23. Lou Z, O'Reilly S, Liang H, Maher VM, Sleight SD, McCormick JJ. (2005). Down-regulation of overexpressed sp1 protein in human fibrosarcoma cell lines inhibits tumor formation. Cancer Res 65: 1007-1017.
24. Marcucci G, Maharry K, Radmacher MD, Mrózek K, Vukosavljevic T, Paschka P et al. (2008). Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with highrisk molecular features: A Cancer and Leukemia Group B Study. J Clin Oncol 26: 5078-5087.
25. Parkin DM, Bray F, Ferlay J, Pisani P. (2005). Global Cancer Statistics, 2002. CA Cancer J Clin 55: 74-108.
26. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I et al. (2008). E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13: 272-286.
27. Qin H, Sun Y, Benveniste EN. (1999). The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase- 2 gene expression in astroglioma cells. J Biol Chem 274: 29130-29137.
28. Ronchetti D, Lionetti M, Mosca L, Agnelli L, Andronache A, Fabris S et al. (2008). An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma. BMC Med Genomic 1: 37.
29. Song YX, Yue ZY, Wang ZN, Xu YY, Luo Y, Xu HM et al. (2011). MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. Mol Cancer 10: 1.
30. Soon PS, Tacon LJ, Gill AJ, Bambach CP, Sywak MS, Campbell PR et al. (2009). miR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer. Clin Cancer Res 15: 7684-7692.
31. Sorrentino A, Liu CG, Addario A, Peschle C, Scambia G, Ferlini C. (2008). Role of microRNAs in drug-resistant ovarian cancer cells. Gynecol Oncol 111: 478-486.
32. Sun Z, Li DM, Wang ZN, Huang BJ, Xu Y, Li K et al. (2009). Prognostic significance of microscopic positive margins for gastric cancer patients with potentially curative resection. Ann Surg Oncol 16: 3028-3037.
33. Sun Z, Wang ZN, Zhu GL, Huang BJ, Li K, Xu Y et al. (2010). Advanced gastric cancer with early cancer macroscopic appearance: Is it worthy of D2 lymphadenectomy?Ann Surg Oncol 17: 1278-1290.
34. Suske G. (1999). The Sp-family of transcription factors. Gene 238: 291-300.
35. Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, Bos PD et al. (2008). Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451: 147-152.
36. Uren RT, Dewson G, Chen L, Coyne SC, Huang DC, Adams JM et al. (2007). Mitochondrial permeabilization relies on BH3 ligands engaging multiple prosurvival Bcl-2 relatives, not Bak. J Cell Biol 177: 277-287.
37. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261.
38. Wada R, Akiyama Y, Hashimoto Y, Fukamachi H, Yuasa Y. (2010). miR-212 is downregulated and suppresses methyl-CpG-binding protein MeCP2 in human gastric cancer. Int J Cancer 127: 1106-1114.
39. Wang F, Zheng Z, Guo J, , Ding X. (2010). Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. Gynecol Oncol 119: 586-593.
40. Wang L, Guan X, Gong W, Yao J, Peng Z, Wei D et al. (2005). Altered expression of transcription factor Sp1 critically impacts the angiogenic phenotype of human gastric cancer. Clin Exp Metastasis 22: 205-213.
41. Wang L, Wei D, Huang S, Peng Z, Le X, Wu TT et al. (2003). Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res 9: 6371-6380.
42. Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen XM, Gao HJ. (2010). Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis. J Dig Dis 11: 50-54.
43. Wu L, Fan J, Belasco JG. (2006). MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci USA 103: 4034-4039.
44. Wu Q, Jin H, Yang Z, Luo G, Lu Y, Li K et al. (2010). MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-Apoptotic gene EGR2. Biochem Biophys Res Commun 392: 340-345.
45. Xu YY, Huang BJ, Sun Z, Lu C, Liu YP. (2007). Risk factors for lymph node metastasis and evaluation of reasonable surgery for early gastric cancer. World J Gastroenterol 13: 5133-5138.
46. Yao JC, Wang L, Wei D, Gong W, Hassan M, Wu TT et al. (2004). Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer. Clin Cancer Res 10: 4109-4117.
47. Yao M, Nguyen TV, Pike CJ. (2005). Beta-Amyloid-induced neuronal apoptosis involves c-Jun N-terminal kinase-dependent downregulation of Bcl-w. J Neurosci 25: 1149-1158.
48. Yu C, Pan K, Xing D, Liang G, Tan W, Zhang L et al. (2002). Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Res 62: 6430-6433.
49. Zhang H, Luo XQ, Zhang P, Huang LB, Zheng YS, Wu J et al. (2009). MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PLoS One 4: E7826.